Log In
BCIQ
Print this Print this
 

Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)

BCIQ
Print ChartPrint this
2 - Pulmonary 4 - Endocrine / Metabolic 1 - Endocrine / Metabolic 2 - Endocrine / Metabolic 1 - Transplant 2 - Pulmonary 1 - Transplant 1 - Hepatic 1 - Endocrine / Metabolic 1 - Hepatic 1 - Endocrine / Metabolic 5 - Pulmonary 2 - Endocrine / Metabolic
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase II/IIIRegistrationMarketed
Endocrine / Metabolic

2

1

1

-

2

1

4

Hepatic

-

1

1

-

-

-

-

Pulmonary

5

-

-

2

-

-

2

Transplant

-

-

1

1

-

-

-




 Products Targeting Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

8

$63,560.0M

$12,694.9M

$85.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today